Benchmark against your competition
Understand how AI crawlers access your site
See where AI gets info about you
Track the queries mentioning your brand
Own your AI narrative
Add GEO to your service offerings
Get recommended in shopping queries
Monitor AI mentions at scale
Gossamer Bio
What AI says about Gossamer Bio
Gossamer Bio is dedicated to enhancing the lives of individuals living with rare diseases through the development of its investigational drug, seralutinib. The company primarily targets conditions like pulmonary arterial hypertension (PAH) and pulmonary hypertension associated with interstitial lung disease (PH-ILD).
Is this your brand?
Claim this profile to keep your information accurate and add what's missing.
Not in this profile yet:
Products & Services
Seralutinib
An investigational drug product aimed at treating pulmonary arterial hypertension and pulmonary hypertension associated with interstitial lung disease.
Common Questions
What is Gossamer Bio focused on?
Gossamer Bio is focused on the development of investigational drugs for the treatment of rare diseases, specifically pulmonary arterial hypertension and pulmonary hypertension associated with interstitial lung disease.
What is seralutinib?
Seralutinib is an investigational drug developed by Gossamer Bio for the treatment of pulmonary arterial hypertension and pulmonary hypertension associated with interstitial lung disease.
Who does Gossamer Bio aim to help?
Gossamer Bio aims to enhance the lives of people living with rare diseases.